Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Shares withheld for taxes See Remarks gave up 908 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Operating Officer gave up 820 shares (to pay taxes)
  3. 4 Grant or award Chief Operating Officer acquired 8,691 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 19,719 shares (grant or award)
  5. 4 Grant or award Senior VP, R&D acquired 3,520 shares (grant or award)
  6. 4 Grant or award CFO acquired 2,540 shares (grant or award)
  7. 4 Grant or award President and CCO acquired 2,880 shares (grant or award)
  8. 4 Open-market sale Director sold 1,000 shares at $193.35 ($193,350)
  9. 4 Open-market sale Chief Operating Officer sold 4,373 shares at $198.08 ($866,204)
  10. 4/A Insider Changes in Ownership
  11. 4 Gift Chief Executive Officer gave 1,000 shares (gift)
  12. 4 Open-market sale See Remarks sold 3,788 shares at $147.13 ($557,328)
  13. 4 Grant or award President and CCO acquired 12,906 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award CFO acquired 5,503 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Director sold 850 shares at $171.38 ($145,673)
  18. 4 Grant or award Director acquired 686 shares (grant or award)
  19. 4 Grant or award Director acquired 686 shares (grant or award)
  20. 4 Grant or award Director acquired 798 shares (grant or award)

Page 7 of 34 · 669 filings